DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health
Bausch Health will pay $1.75 per share plus up to $350 million in aggregate sales milestones Transaction expected to close in the third quarter of 2025 CUPERTINO, Calif., Aug. 12, 2025 /PRNewswire/...
Are there any contingent or hidden liabilities (e.g., pending litigation, debt covenants) that could affect the dealâs net benefit?
What is the marketâs perception of the deal risk, and how is it reflected in options activity and shortâinterest on DRRX stock?
How might the salesâmilestone structure influence DRRXâs growth strategy and product rollout plans postâclose?
15 days ago